vanillin has been researched along with Liver Neoplasms in 5 studies
Vanilla: A plant genus of the family ORCHIDACEAE that is the source of the familiar flavoring used in foods and medicines (FLAVORING AGENTS).
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vanillin is a natural compound, a primary component of the extract of the vanilla bean which possesses varieties of pharmacological features including anti-oxidant, anti-inflammatory, anti-bacterial and anti-tumor." | 5.48 | Evidence of vanillin binding to CAMKIV explains the anti-cancer mechanism in human hepatic carcinoma and neuroblastoma cells. ( Ahamad, S; Ahmad, F; Hassan, MI; Islam, A; Khan, P; Luqman, S; Naz, H; Tarique, M, 2018) |
| "Vanillin has been reported to exhibit anti-invasive and antimetastatic activities by suppressing the enzymatic activity of matrix metalloproteinase-9 (MMP-9)." | 5.35 | Vanillin inhibits matrix metalloproteinase-9 expression through down-regulation of nuclear factor-kappaB signaling pathway in human hepatocellular carcinoma cells. ( Ho, TY; Hsiang, CY; Liang, JA; Lo, HY; Wu, SL, 2009) |
| "Vanillin is a natural compound, a primary component of the extract of the vanilla bean which possesses varieties of pharmacological features including anti-oxidant, anti-inflammatory, anti-bacterial and anti-tumor." | 1.48 | Evidence of vanillin binding to CAMKIV explains the anti-cancer mechanism in human hepatic carcinoma and neuroblastoma cells. ( Ahamad, S; Ahmad, F; Hassan, MI; Islam, A; Khan, P; Luqman, S; Naz, H; Tarique, M, 2018) |
| "Vanillin has been reported to exhibit anti-invasive and antimetastatic activities by suppressing the enzymatic activity of matrix metalloproteinase-9 (MMP-9)." | 1.35 | Vanillin inhibits matrix metalloproteinase-9 expression through down-regulation of nuclear factor-kappaB signaling pathway in human hepatocellular carcinoma cells. ( Ho, TY; Hsiang, CY; Liang, JA; Lo, HY; Wu, SL, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, X | 1 |
| Huang, J | 1 |
| Lu, J | 1 |
| He, F | 1 |
| Wang, F | 1 |
| Li, S | 1 |
| Zhong, H | 1 |
| Yu, H | 1 |
| Pu, W | 1 |
| Naz, H | 1 |
| Tarique, M | 1 |
| Khan, P | 1 |
| Luqman, S | 1 |
| Ahamad, S | 1 |
| Islam, A | 1 |
| Ahmad, F | 1 |
| Hassan, MI | 1 |
| Liang, JA | 1 |
| Wu, SL | 1 |
| Lo, HY | 1 |
| Hsiang, CY | 1 |
| Ho, TY | 1 |
| Tsuda, H | 1 |
| Uehara, N | 1 |
| Iwahori, Y | 1 |
| Asamoto, M | 1 |
| Iigo, M | 1 |
| Nagao, M | 1 |
| Matsumoto, K | 1 |
| Ito, M | 1 |
| Hirono, I | 1 |
| Kaplan, DE | 1 |
5 other studies available for vanillin and Liver Neoplasms
| Article | Year |
|---|---|
Active compounds and potential targets of Shuganning injection in the treatment of hepatocellular carcinoma by network pharmacology and in vitro validation.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; MAP Kinase Signalin | 2023 |
Evidence of vanillin binding to CAMKIV explains the anti-cancer mechanism in human hepatic carcinoma and neuroblastoma cells.
Topics: Antineoplastic Agents; Benzaldehydes; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Carcinoma, | 2018 |
Vanillin inhibits matrix metalloproteinase-9 expression through down-regulation of nuclear factor-kappaB signaling pathway in human hepatocellular carcinoma cells.
Topics: Benzaldehydes; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-R | 2009 |
Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat.
Topics: Allyl Compounds; Animals; Anticarcinogenic Agents; Antioxidants; Benzaldehydes; beta Carotene; Carci | 1994 |
A Matter of TACEte: Plain Vanilla or Combination?
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Humans; Liver Neoplasm | 2020 |